1 |
Tugizova M, Vlahovic L, Tomczak A, Wetzel NS, Han MH. New Therapeutic Landscape in Neuromyelitis Optica. Curr Treat Options Neurol 2021;23:13. [PMID: 33814893 DOI: 10.1007/s11940-021-00667-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
2 |
Ferrante P, Mora JA, Salazar L, Sáez EM, Auger C, Rovira À. MR imaging findings in primary spinal cord glioblastoma. Radiol Case Rep 2021;16:72-7. [PMID: 33193932 DOI: 10.1016/j.radcr.2020.10.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
3 |
Czarnecka D, Oset M, Karlińska I, Stasiołek M. Cognitive impairment in NMOSD-More questions than answers. Brain Behav 2020;10:e01842. [PMID: 33022898 DOI: 10.1002/brb3.1842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
4 |
Freiha J, Riachi N, Chalah MA, Zoghaib R, Ayache SS, Ahdab R. Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature. J Clin Med 2020;9:E3100. [PMID: 32992918 DOI: 10.3390/jcm9103100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
5 |
Zhou Y, Zhang Y, Han J, Yang M, Zhu J, Jin T. Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases. J Transl Med 2020;18:131. [PMID: 32183811 DOI: 10.1186/s12967-020-02289-w] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
|
6 |
Bui ML, Gould JK, Mentreddy A, Sigsbee E, Lalama H. Neuromyelitis Optica Spectrum Disorder: A Rare Case of Isolated Brainstem Syndrome. Cureus 2019;11:e5644. [PMID: 31700746 DOI: 10.7759/cureus.5644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
7 |
Fragoso YD, Ruocco HH, Dias RM, Cabeça H, Gonçalves R, de Carvalho Sousa NA, Spessotto CV, Tauil CB, Alves-Leon SV, Gomes S, Gonçalves MVM, Machado SCN, Anacleto A, Correa EC, Pimentel MLV, Santos GAC. Late Onset of Neuromyelitis Optica Spectrum Disorders. Neurol Ther 2019;8:477-82. [PMID: 31267407 DOI: 10.1007/s40120-019-0143-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
8 |
Bejerot S, Hesselmark E, Mobarrez F, Wallén H, Hietala MA, Nybom R, Wetterberg L. Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report. J Med Case Rep 2019;13:27. [PMID: 30696485 DOI: 10.1186/s13256-018-1929-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
9 |
Chroustová I, Mareš M, Ungermann L, Ehler E. Myelin Oligodendrocyte Glycoprotein Antibody Associated Transverse Myelitis. Acta Med (Hradec Kralove, Czech Repub ) 2019;62:123-126. [DOI: 10.14712/18059694.2019.136] [Reference Citation Analysis]
|
10 |
Suponeva NA, Bakulin IS, Rizvanova AS, Konovalov RN, Konovalov YE. Response to the article “Bickerstaff brainstem encephalitis, acute transverse myelitis, and acute motor axonal neuropathy: diagnostic and treatment challenges in patients with concomitant syndromes. Clinical observation”. Neuromuscular Diseases 2018;8:65-67. [DOI: 10.17650/2222-8721-2018-8-3-65-69] [Reference Citation Analysis]
|
11 |
Campbell A, Ogundipe OA. Neuromyelitis optica spectrum disorder presenting in an octogenarian. BMJ Case Rep 2018;2018:bcr-2018-225601. [PMID: 30196259 DOI: 10.1136/bcr-2018-225601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|